Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Cipla arm, Alvotech enter partnership for commercialization of adalimumab biosimilar AVT02

      Cipla arm, Alvotech enter partnership for commercialization of adalimumab biosimilar AVT02

      Medical Dialogues Bureau29 July 2019 9:45 AM IST
      Under the partnership, Alvotech will be responsible for the development and supply of AVT02, an adalimumab biosimilar, while Cipla Gulf will be...
      Pfizer, Mylan in talks to merge off-patent drugs business

      Pfizer, Mylan in talks to merge off-patent drugs business

      Medical Dialogues Bureau29 July 2019 9:30 AM IST
      Mylan shareholders would receive a little more than 40 per cent of the newly formed entity, with Pfizer shareholders receiving the remainder, the...
      Novartis CEO Vas Narasimhan vows not to sell Sandoz generics unit

      Novartis CEO Vas Narasimhan vows not to sell Sandoz generics unit

      Medical Dialogues Bureau29 July 2019 9:17 AM IST
      Novartis is revamping Sandoz, a process Narasimhan has previously said will take roughly the next year and a half. He has already sold a generic U.S....
      Alkem Labs Founder Samprada Singh passes away at the age of 92 years

      Alkem Labs Founder Samprada Singh passes away at the age of 92 years

      Medical Dialogues Bureau29 July 2019 9:00 AM IST
      Patna: Mumbai-based drugmaker, Alkem Laboratories Founder and Chairman Emeritus, Samprada Singh expired on Saturday at the age of 92 years after a...
      Biocon Q1 profit rises 72 percent to Rs 206 crore

      Biocon Q1 profit rises 72 percent to Rs 206 crore

      Medical Dialogues Bureau28 July 2019 10:00 AM IST
      "Robust performance by our biologics and small molecules business segments fuelled the 25 per cent growth in Q1 FY20 revenue to Rs 1,490 crore,"...
      Bayer high-precision cancer drug Vitrakvi in frame to receive first EU nod

      Bayer high-precision cancer drug Vitrakvi in frame to receive first EU nod

      Medical Dialogues Bureau28 July 2019 9:45 AM IST
      Bayer earlier this year took full control of Vitrakvi in a deal with Eli Lilly's Loxo Oncology, and the European thumbs-up follows U.S. regulatory...
      Hamdard Labs launches Wellness Centres in Ghaziabad, Meerut

      Hamdard Labs launches Wellness Centres in Ghaziabad, Meerut

      Medical Dialogues Bureau28 July 2019 9:30 AM IST
      The objective is to spread the natural healing touch of Unani and reach out to people wanting natural, herbal treatment for lifestyle diseases, and a...
      Bristol-Myers posts strong second quarter as Eliquis, Orencia sales propel

      Bristol-Myers posts strong second quarter as Eliquis, Orencia sales propel

      Medical Dialogues Bureau28 July 2019 9:17 AM IST
      Sales of Eliquis, which Bristol-Myers shares with Pfizer Inc (PFE.N), rose 24% to $2.04 billion, while Orencia sales rose 9% to $778 million, both...
      GW Pharma cannabis drug Epidiolex wins European panel nod

      GW Pharma cannabis drug Epidiolex wins European panel nod

      Medical Dialogues Bureau28 July 2019 9:15 AM IST
      Epidiolex is made up of cannabidiol (CBD), one of the hundreds of molecules found in the marijuana plant, and contains less than 0.1 per cent of...
      Important to regulate use of antibiotics in animals, humans: Harsh Vardhan

      Important to regulate use of antibiotics in animals, humans: Harsh Vardhan

      Medical Dialogues Bureau27 July 2019 10:00 AM IST
      "Use of antibiotics in chickens, in particular, is expected to triple in India by 2030 and therefore it is important to regulate the use of...
      Indoco Remedies receives EIR from USFDA for sterile, solid dosages facility in Goa

      Indoco Remedies receives EIR from USFDA for sterile, solid dosages facility in Goa

      Medical Dialogues Bureau27 July 2019 9:45 AM IST
      The inspection was held from May 27-June 4, 2019 and the company received four Form 483 observations, Indoco Remedies said in a filing to BSE.NEW...
      Do not BAN, regulate sale, use of e-cigarettes, other ENDS devices: Trade representatives of ENDS

      Do not BAN, regulate sale, use of e-cigarettes, other ENDS devices: Trade representatives of ENDS

      Medical Dialogues Bureau27 July 2019 9:30 AM IST
      The appeal comes days after the Delhi High Court directed the Kejriwal government to urgently look into the matter of regulating the sale and...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok